Sven-Erik Lennart Nilsson
Chief Executive Officer at ENKAM Pharmaceuticals A/S
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan Evert Lilja | M | - |
Protista International AB
 Protista International AB Pharmaceuticals: MajorHealth Technology Protista International AB develops and manufactures pharmaceutical products. It focuses on research in the area of biotechnology with a focus on fermentation and bioseparation. The company was founded in 2001 and is headquartered in Bjuv, Sweden.
Migrata U.K. Ltd.
 Migrata U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Desert Shield Technologies Ltd., Migrata U.K. Ltd. provides business support services. The company is based in London, UK. | - |
| Hans Jungvid | M | - |
Protista International AB
Protista International AB Pharmaceuticals: MajorHealth Technology Protista International AB develops and manufactures pharmaceutical products. It focuses on research in the area of biotechnology with a focus on fermentation and bioseparation. The company was founded in 2001 and is headquartered in Bjuv, Sweden. | - |
| Inger Holgersson | F | - |
Protista International AB
Protista International AB Pharmaceuticals: MajorHealth Technology Protista International AB develops and manufactures pharmaceutical products. It focuses on research in the area of biotechnology with a focus on fermentation and bioseparation. The company was founded in 2001 and is headquartered in Bjuv, Sweden. | - |
| Andreas Monthán | M | - |
Protista International AB
Protista International AB Pharmaceuticals: MajorHealth Technology Protista International AB develops and manufactures pharmaceutical products. It focuses on research in the area of biotechnology with a focus on fermentation and bioseparation. The company was founded in 2001 and is headquartered in Bjuv, Sweden. | - |
| Andreas Loizou | M | - |
Migrata U.K. Ltd.
Migrata U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Desert Shield Technologies Ltd., Migrata U.K. Ltd. provides business support services. The company is based in London, UK. | - |
| Mary Ioannou | F | - |
Migrata U.K. Ltd.
Migrata U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Desert Shield Technologies Ltd., Migrata U.K. Ltd. provides business support services. The company is based in London, UK. | - |
| Ana Loredana Peste | F | - |
Migrata U.K. Ltd.
Migrata U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Desert Shield Technologies Ltd., Migrata U.K. Ltd. provides business support services. The company is based in London, UK. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan-Eric Österlund | M | 79 |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 15 years |
| Peter Holme Jensen | M | 54 |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 8 years |
| Morten Albrechtsen | M | 60 |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 18 years |
| Stephen Rees | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Volodymyr Berezin | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 5 | 41.67% |
| Sweden | 4 | 33.33% |
| United Kingdom | 4 | 33.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sven-Erik Lennart Nilsson
- Personal Network
